Skip to Content

Breast Cancer Canada — Call for Proposals: Lobular Carcinoma

December 3, 2025

Time to read: 1 minutes

Overview

Breast Cancer Canada is now accepting applications for the 2026 Research Grant competition, awarding a total of $250,000 CAD to accelerate precision oncology in Lobular Carcinoma breast cancer. This national grant program is designed to fuel innovation in precision diagnostics and targeted treatment driven by Canadian research teams who are shaping the future of breast cancer care.

Funding Value and Duration

Research FocusBudget Category 1Budget Category 2
Targeted Diagnostics (Screening, Detection or Follow-up)$75,000 (3 x $25,000 annually)$50,000 (2 x $25,000 annually)
Targeted Treatment (Surgery, Medicine or Radiation)$75,000 (3 x $25,000 annually)$50,000 (2 x $25,000 annually)

Sponsor’s Website

Breast Cancer Canada

Internal Contacts

Katie Harriman

Deadlines

DeadlineDate
Faculty DeadlineConsult your Faculty Research Facilitator
OVPRII Approval Form DeadlineDecember 5, 2025
Letter of IntentDecember 12, 2025 by 5 p.m. (PT)
Submission DeadlineFebruary 13, 2026 by 5 p.m. (PT)

Submitting Your Application

  1. Log in to cuResearch and submit an internal Carleton Approval Form. Review the cuResearch user’s manual.
  2. Submit an external application to Breast Cancer Canada by following their submission guidelines.